Loading…
FcγRIIa: A New Cardiovascular Risk Marker
Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that ha...
Saved in:
Published in: | Journal of the American College of Cardiology 2018-07, Vol.72 (2), p.237-238 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 238 |
container_issue | 2 |
container_start_page | 237 |
container_title | Journal of the American College of Cardiology |
container_volume | 72 |
creator | Schneider, David J. McMahon, Sean R. Chava, Sreedivya Taatjes-Sommer, Heidi S. Meagher, Sean Ehle, Gregory L. Brummel-Ziedins, Kathleen E. |
description | Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time. |
doi_str_mv | 10.1016/j.jacc.2018.04.046 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2066475378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S073510971834720X</els_id><sourcerecordid>2066475378</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963</originalsourceid><addsrcrecordid>eNpdkNFKwzAUhoMobk5fwAspeCNC60nSJo14M4bTwVQYeh3S9BTadetM1onP5Xv4TLZMb4Qfzs3Hz38-Qs4pRBSouKmiylgbMaBpBHEXcUCGNEnSkCdKHpIhSJ6EFJQckBPvKwAQKVXHZMCUkoIpOSTXU_v9tZjNzG0wDp7xI5gYl5fNznjb1sYFi9IvgyfjluhOyVFhao9nv3dE3qb3r5PHcP7yMJuM5yEyxbZhUXDFLaOKCZkiL0Qas8xkKQNpmERmeAIUbRGbWFmIMQNFlQFZUEtzpQQfkat978Y17y36rV6V3mJdmzU2rdcMhIhlwmXaoZf_0Kpp3bpb11O8GwFpX3jxS7XZCnO9ceXKuE_9Z6ED7vYAdm_tSnTa2xLXFvPSod3qvCk1Bd1L15Xupeteuoa4i-A_xDVw5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2063219086</pqid></control><display><type>article</type><title>FcγRIIa: A New Cardiovascular Risk Marker</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</creator><creatorcontrib>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</creatorcontrib><description>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2018.04.046</identifier><identifier>PMID: 29976297</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiology ; Diabetes ; Patients</subject><ispartof>Journal of the American College of Cardiology, 2018-07, Vol.72 (2), p.237-238</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jul 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29976297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, David J.</creatorcontrib><creatorcontrib>McMahon, Sean R.</creatorcontrib><creatorcontrib>Chava, Sreedivya</creatorcontrib><creatorcontrib>Taatjes-Sommer, Heidi S.</creatorcontrib><creatorcontrib>Meagher, Sean</creatorcontrib><creatorcontrib>Ehle, Gregory L.</creatorcontrib><creatorcontrib>Brummel-Ziedins, Kathleen E.</creatorcontrib><title>FcγRIIa: A New Cardiovascular Risk Marker</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</description><subject>Cardiology</subject><subject>Diabetes</subject><subject>Patients</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkNFKwzAUhoMobk5fwAspeCNC60nSJo14M4bTwVQYeh3S9BTadetM1onP5Xv4TLZMb4Qfzs3Hz38-Qs4pRBSouKmiylgbMaBpBHEXcUCGNEnSkCdKHpIhSJ6EFJQckBPvKwAQKVXHZMCUkoIpOSTXU_v9tZjNzG0wDp7xI5gYl5fNznjb1sYFi9IvgyfjluhOyVFhao9nv3dE3qb3r5PHcP7yMJuM5yEyxbZhUXDFLaOKCZkiL0Qas8xkKQNpmERmeAIUbRGbWFmIMQNFlQFZUEtzpQQfkat978Y17y36rV6V3mJdmzU2rdcMhIhlwmXaoZf_0Kpp3bpb11O8GwFpX3jxS7XZCnO9ceXKuE_9Z6ED7vYAdm_tSnTa2xLXFvPSod3qvCk1Bd1L15Xupeteuoa4i-A_xDVw5Q</recordid><startdate>20180710</startdate><enddate>20180710</enddate><creator>Schneider, David J.</creator><creator>McMahon, Sean R.</creator><creator>Chava, Sreedivya</creator><creator>Taatjes-Sommer, Heidi S.</creator><creator>Meagher, Sean</creator><creator>Ehle, Gregory L.</creator><creator>Brummel-Ziedins, Kathleen E.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180710</creationdate><title>FcγRIIa: A New Cardiovascular Risk Marker</title><author>Schneider, David J. ; McMahon, Sean R. ; Chava, Sreedivya ; Taatjes-Sommer, Heidi S. ; Meagher, Sean ; Ehle, Gregory L. ; Brummel-Ziedins, Kathleen E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cardiology</topic><topic>Diabetes</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, David J.</creatorcontrib><creatorcontrib>McMahon, Sean R.</creatorcontrib><creatorcontrib>Chava, Sreedivya</creatorcontrib><creatorcontrib>Taatjes-Sommer, Heidi S.</creatorcontrib><creatorcontrib>Meagher, Sean</creatorcontrib><creatorcontrib>Ehle, Gregory L.</creatorcontrib><creatorcontrib>Brummel-Ziedins, Kathleen E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, David J.</au><au>McMahon, Sean R.</au><au>Chava, Sreedivya</au><au>Taatjes-Sommer, Heidi S.</au><au>Meagher, Sean</au><au>Ehle, Gregory L.</au><au>Brummel-Ziedins, Kathleen E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FcγRIIa: A New Cardiovascular Risk Marker</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2018-07-10</date><risdate>2018</risdate><volume>72</volume><issue>2</issue><spage>237</spage><epage>238</epage><pages>237-238</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Platelet expression of FcγRIIa reflects megakaryocyte production that is increased by interferon gamma (3). [...]platelet expression of FcγRIIa would be expected to change as a reflection of systemic inflammation and would be less likely to exhibit the substantial intraindividual variability that has been observed with currently available tests of platelet function (1). [...]platelet FcγRIIa expression provides a tangible link between systemic inflammation and increased platelet reactivity. In summary, we found that increased platelet FcγRIIa expression identifies patients at greater risk of CVE. Because FcγRIIa augments platelet reactivity (2), we propose that platelet FcγRIIa expression is a new marker of increased platelet reactivity capable of identifying patients at increased risk of CVE and that platelet FcγRIIa expression is likely to be a more consistent marker of increased platelet reactivity over time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29976297</pmid><doi>10.1016/j.jacc.2018.04.046</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-1097 |
ispartof | Journal of the American College of Cardiology, 2018-07, Vol.72 (2), p.237-238 |
issn | 0735-1097 1558-3597 |
language | eng |
recordid | cdi_proquest_miscellaneous_2066475378 |
source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
subjects | Cardiology Diabetes Patients |
title | FcγRIIa: A New Cardiovascular Risk Marker |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A03%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fc%CE%B3RIIa:%20A%20New%20Cardiovascular%20Risk%20Marker&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Schneider,%20David%20J.&rft.date=2018-07-10&rft.volume=72&rft.issue=2&rft.spage=237&rft.epage=238&rft.pages=237-238&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2018.04.046&rft_dat=%3Cproquest_pubme%3E2066475378%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e292t-ff393c2192678e3f6842bab8207a27e2a3501ecf4a49c04eb0919a07f1c1d9963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2063219086&rft_id=info:pmid/29976297&rfr_iscdi=true |